Industries > Pharma > Global Biomarkers Market Forecast 2017-2027

Global Biomarkers Market Forecast 2017-2027

Biomarker Services, Biomarker Diagnostics, Biomarker Discovery, Genomics, Proteomics, Bioinformatics, Cancer, Cardiovascular Diseases, CNS, Autoimmune Diseases

PUBLISHED: 18 October 2017
PAGES: 206
PRODUCT CODE: PHA0248

Clear
WOOCS 2.2.1

The global biomarkers market is expected to grow at a CAGR of 9.1% in the first half of the forecast period. In 2016, the largest sector of the market was biomarker discovery, which encompasses revenues for instruments and reagents, as well as the other costs associated with in-house biomarker research and development. This sector accounted for 49.3% of the global biomarkers market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 206-page report you will receive 66 tables and 59 figures– all unavailable elsewhere.

The 206-page report provides clear detailed insight into the global biomarkers market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Biomarkers Market Research from 2017-2027

• This report also breaks down the revenue forecast for the global biomarkers market by Sector:
– Biomarker Services
– Biomarker Diagnostics
– Biomarker Discovery

• This report also breaks down the revenue forecast for the global biomarkers market by Discipline:
– Genomics
– Proteomics
– Bioinformatics
– Other

• This report also breaks down the revenue forecast for the global biomarkers market by Therapeutic Indication:
– Cancer
– Cardiovascular Diseases
– CNS,
– Autoimmune Diseases
– Other

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– US
– EU5 (further segmented into France, Germany, the UK, Spain and Italy)
– Japan
– China
– India
– Russia
– Brazil
– RoW

Global Biomarkers Market Forecast 2017-2027

• Our study gives qualitative analysis of the biomarkers market. It includes a SWOT and STEP Analysis.

• Our study discusses the selected leading companies that are the major players in the biomarkers industry. These companies are biomarker service providers, biomarker technology providers and biomarker diagnostic developers:
– Quintiles IMS Holdings Inc
– Laboratory Corporation of America Holdings
– Parexel
– Charles River Laboratories
– ICON plc
– WuXi PharmaTec
– Caprion Proteomics
– Proteome Sciences
– Pacific Biomarkers
– Oxford Gene Technology (OGT)
– Worldwide Clinical Trials (WWC)
– Agilent
– AB SCIEX
– QIAGEN
– Axela Inc
– Thermo Fisher Scientific
– Quest Diagnostics
– Myriad Genetics
– Genomic Health
– Critical Diagnostics
– Epigenomics
– MDxHealth (formerly OncoMethylome)

• Our study also discusses activities of the big pharmaceutical companies that are investing in biomarkers development through, for example, collaborations with CROs:
– Pfizer
– Novartis
– Roche Diagnostics
– Ventana Medical Systems
– Merck & Co.
– Sanofi
– GSK
– Abbott Laboratories
– AstraZeneca

Visiongain’s study is intended for anyone requiring commercial analyses for the global biomarkers market. You find data, trends and predictions.

Buy our report today Global Biomarkers Market Forecast 2017-2027: Biomarker Services, Biomarker Diagnostics, Biomarker Discovery, Genomics, Proteomics, Bioinformatics, Cancer, Cardiovascular Diseases, CNS, Autoimmune Diseases.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Biomarkers Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Biomarkers Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes ePharmacy Market Report 2021-2031

The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.

06 May 2021

READ

Visiongain Publishes Protein Labelling Reagents for Research Use Only (RUO) Market Report 2021-2031

Increasing investment in R&D for proteomics research, by both public and private organizations, is one of the major contributors to the growth of the protein labelling reagents market. The increasing prevalence of chronic diseases is also expected to contribute to the growth of this market.

05 May 2021

READ

Visiongain Publishes Aptamer Technologies Market Report 2021-2031

Over the last few years, the aptamers has gained widespread attention due to the technological advancements and growth in understanding of the oligonucleotide therapeutics that inhabit the human body.

29 April 2021

READ

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031

Rising prevalence of inflammatory bowel disease including Crohn’s disease and ulcerative colitis; raising awareness for IBD in developing countries; escalating investment in drug R&D by pharmaceutical companies; new product launches worldwide, growing chronic diseases healthcare awareness are some of the major factors that boosting the growth of global IBD drugs market.

29 April 2021

READ

Categories